The Global Fund explores innovative finance instruments to help unlock financial flows from private and public sources
To many, the Global Fund is known primarily as a source of funding—a place governments can turn to for an injection of cash for programs aimed at ending the scourges of AIDS, tuberculosis and malaria. And the Global Fund’s main use and focus of its innovative finance program has been on raising the funds needed to meet country demand for these otherwise unaffordable programs.
Capacity issues and delays in implementation plague otherwise successful Global Fund grants to Zambia, OIG says
Working towards the elimination of malaria in the Greater Mekong Sub-Region (GMS) of Southeast Asia is the goal of the second phase of the Regional Artemisinin-resistance Initiative (RAI).
In the first half of 2016, through programs supported by the Global Fund, another 787,000 people were put on antiretroviral treatment (ART) for HIV, bringing the total to date to 10 million, a 9% increase over end-2015 results and a 17% increase over the number a year ago. Three countries account for 77% of the increase from six months ago: Kenya (52%), Tanzania (16%) and Mozambique (9%).